Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” The clinical trial details and record history are unchanged.
    Difference
    0.6%
    Check dated 2026-10-26T14:28:23.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:40:43.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:48:04.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.7.0 was added to the study record history, and the previous v3.6.6 entry was removed.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:18.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision entry updated to v3.6.6, replacing v3.6.5 in the page history. This reflects a minor system update to the history records and does not change study data or content.
    Difference
    0.1%
    Check dated 2026-08-31T17:19:32.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The history now includes a new revision label v3.6.5, replacing the previous v3.6.4 in the list.
    Difference
    0.1%
    Check dated 2026-08-10T17:42:33.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.